Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120758580A reveals enzymatic route for (S)-chiral amines. High ee value, mild conditions. Reliable supplier for pharma intermediates.
Novel mixed-solvent synthesis for high-purity chiral diamine ruthenium catalysts. Reduces recrystallization needs and boosts yield for asymmetric catalysis applications.
Novel dehydroabietylamine-based catalyst enables high-yield Morita-Baylis-Hillman reactions with up to 94% yield and 89% ee, offering cost-effective asymmetric synthesis solutions.
Patent CN120020113A reveals a novel iridium-catalyzed method for high-purity chiral amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN119040289B enables high-purity chiral amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Patent CN107286203B details a novel route for chiral Ugi's amine. Discover cost-effective manufacturing and supply chain advantages for Josiphos ligands.
Patent CN105712812A reveals high-efficiency chiral amine synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing processes.
Novel N-monosulfonated chiral diamines enable efficient aqueous phase asymmetric hydrogenation, reducing solvent waste and costs for API intermediates.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN107445999A enables high-purity chiral cyclic amines via Rhodium catalysis. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable technology.
Patent CN116064449A discloses stable transaminase mutants for bulky chiral amines. Enables green synthesis, cost reduction, and reliable supply for pharmaceutical intermediates.
Patent CN110628739B reveals high-efficiency enzymatic synthesis for chiral amines. Achieve >99% ee and reduced costs with scalable biocatalytic solutions.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN116178219B reveals metal-free catalytic route. Enables cost reduction in pharmaceutical intermediate manufacturing with high enantioselectivity.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN106111189B reveals a novel chiral pyridoxamine catalyst enabling mild synthesis of alpha-amino acids with high ee values and scalable manufacturing potential.
Patent CN115975968B reveals novel amine dehydrogenase mutants for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.